Study adds two new strains to the list of potential antihypertensive probiotics

An estimated 40% of the global adult population have high blood pressure, or hypertension, which puts people at risk of cardiovascular disease and other dangerous health conditions.

RO-7566802 by Genentech USA for Solid Tumor: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 28, 2023

A dilemma in ALS, the first MASH drug, & why gene therapy is hard

What happens when an approved drug doesn’t work? Why don’t patients want gene therapy? And is MASH still a big deal? We cover all that

March 14, 2024

Fatal Christmas Tree; A Whole Lot of Fraud; Chatbots Relieve Seniors’ Loneliness

Note that some links may require registration or subscription. In observance of the holiday season, Morning Break will not be published December 25-26 and will

December 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.